With Peru's anchovy fishery opening its 2026 season with its lowest quota in a decade, Matts Johansen argues that aquaculture's growing appetite for omega-3s, not just El Niño, is what should actually be keeping supplement brands up at night.

In the ninth episode, Nicholas and Lana unpack several longevity launches making waves, and why regulatory clearance, novelty, and clinical data are 3 separate things brands shouldn't blur together.

DolCas Biotech is featuring the turmeric-derived ingredient Curcugen in Mānukora’s Mānuka honey and Numin’s cognitive-support drink.

The company says it will feature studies on vitamin K2, choline, folate, and MSM, along with beverage concepts and a first-time pet corner.

The agency’s editorial identifies needs across six areas, including new methods for novel products, gut microbiome data, and AI-supported risk assessment.

The company says it will center on positive aging, with a focus on lutein research beyond vision, the Gutopia platform, and Slendesta for the GLP-1 market.

The Council for Responsible Nutrition says its Morning Consult survey also found that three in four adults use supplements and that cost is the most commonly cited barrier.

A look at the market data and functional ingredient innovations driving the next generation of nutrition bars.